Buscar resultados de ensayos clínicos

Patrocinado por

Paramyxoviridae Infections - 16 Studies Found

Estado Estudiar
Completed Nombre del estudio: An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection
Condición: Parainfluenza
Fecha: 2013-07-11
Intervenciones:
  • Drug: DAS181-F02 Dry Powder in Bulk

Active, not recruiting Nombre del estudio: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen
Condición: Parainfluenza
Fecha: 2012-07-17
Intervenciones:
  • Drug: DAS181 dry powder, formulation F02
  • D
Completed Nombre del estudio: Safety of a Live Attenuated Human Parainfluenza Virus Type 2 (HPIV2) Vaccine for Adults, Children, and Infants
Condición: Human Parainfluenza Virus 2
Fecha: 2010-06-07
Intervenciones:
  • Biological: Standard Dose HPIV2 Vaccine

Withdrawn Nombre del estudio: DAS181 in Patients With Parainfluenza
Condición: Parainfluenza Infection
Fecha: 2011-09-24
Intervenciones:
  • Drug: DAS181 20 mg per day of

Completed Nombre del estudio: Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine
Condición:
  • Parainfluenza
  • Virus Diseases

Fecha: 2008-03-05
Intervenciones:
  • Biological: rHPIV1 84/del170/942A, Lot PIV1 #104A vaccine

Completed Nombre del estudio: A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and Toddlers
Condición:
  • Parainfluenza
  • Respiratory Viral Infections

Fecha: 2005-09-12
Intervenciones: Biological: Sendai virus vaccine Enders strain; a live, unmodified intranasally administered Sendai viru
Completed Nombre del estudio: Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study
Condición: Respiratory Syncytial Virus (RSV) Infection
Fecha: 2016-03-21
Intervenciones:
  • Drug: BTA-C585 oral capsule Ot
Completed Nombre del estudio: Evaluating the Infectivity, Safety, and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants 6 to 24 Months of Age
Condición: Respiratory Syncytial Virus Infections
Fecha: 2017-03-23
Intervenciones:
  • Biological: D46/NS2/N/ΔM2-2-HindIII

Completed Nombre del estudio: Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants and Children 6 to 24 Months of Age
Condición: Respiratory Syncytial Virus Infections
Fecha: 2017-03-28
Intervenciones:
  • Biological: RSV D46/NS2/N/ΔM2-2-HindIII Vaccine

Active, not recruiting Nombre del estudio: A Study to Rank Different Dosages of Antigen of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A), Based on Their Immune Response and Safety, When Administered to Healthy Adult Women
Condición: Respiratory Syncytial Virus Infections
Fecha: 2016-11-03
Intervenciones:
  • Biological: RSV Vaccine (GSK3003891A) formulation 1

Next >>>